Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI

Clinical trial NCT05103813 · UNKNOWN

Trial details

NCT number: NCT05103813
Sponsor: Shenzhen People's Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2022-05-01
Primary completion: 2022-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.